Science Explorer Back to mapMap
Discussion
Institution · Clinical Research Puerto Rico

Most cited papers from Clinical Research Puerto Rico

Clinical Research Puerto Rico

What are the most cited papers from Clinical Research Puerto Rico?

The most cited paper from Clinical Research Puerto Rico is "Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults" (Schlomo Staszewski, Javier O Morales-Ramirez, Karen T. Tashima et al., 1999), with 1,010 citations. Next come "Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America" (958) and "Pain and Treatment of Pain in Minority Patients with Cancer: The Eastern Cooperative Oncology Group Minority Outpatient Pain Study" (517).

Showing 50 of 61 papers. Every paper with more than 20 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults Schlomo Staszewski, Javier O Morales-Ramirez, Karen T. Tashima et al. · New England Journal of Medicine Open access 16 Dec 1999 1,010
2 Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America Luis Angel Villar et al. · New England Journal of Medicine Open access 3 Nov 2014 958
3 Pain and Treatment of Pain in Minority Patients with Cancer: The Eastern Cooperative Oncology Group Minority Outpatient Pain Study Charles S. Cleeland, Rene Gonin, Luis Baez et al. · Annals of Internal Medicine Nov 1997 517
4 Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1 Susanna Naggie et al. · New England Journal of Medicine Open access 21 Jul 2015 472
5 Rapid and Durable Antiretroviral Effect of the HIV-1 Integrase Inhibitor Raltegravir as Part of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection Martin Markowitz, Bach‐Yen Nguyen, Eduardo Gotuzzo et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes 10 Sep 2007 408
6 Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518, a Novel Inhibitor of HIV-1 Integrase, Dosed As Monotherapy for 10 Days in Treatment-Naive HIV-1-Infected Individuals Martin H. Markowitz, Javier O Morales-Ramirez, Bach‐Yen Nguyen et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes 13 Nov 2006 367
7 Psychosocial Characteristics of Physically Abused Children and Adolescents Alan J. Flisher, RACHEL A. KRAMER, Christina W. Hoven et al. · Journal of the American Academy of Child & Adolescent Psychiatry Open access 1997 169
8 Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial Joel E. Gallant, Eric S. Daar, François Raffi et al. · The Lancet HIV 14 Mar 2016 166
9 Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients Edwin DeJesus, Benjamin Young, Javier O Morales-Ramirez et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes 21 May 2009 135
10 Dialogues: The Science and Power of Storytelling WENDY A. SUZUKI, Mónica I. Feliú-Mójer, Uri Hasson et al. · Journal of Neuroscience Open access 31 Oct 2018 129
11 Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial Anton Louis Pozniak, Javier O Morales-Ramirez, Elly Tebasoboke Katabira et al. · AIDS 28 Nov 2009 118
12 Dolutegravir/Abacavir/Lamivudine versus Current ART in Virally Suppressed Patients (STRIIVING): A 48-Week, Randomized, Non-Inferiority, Open-Label, Phase IIIb Study Benoît Trottier, Jordan E. Lake, Ken Logue et al. · Antiviral Therapy May 2016 110
13 Sustained Antiretroviral Effect of Raltegravir After 96 Weeks of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection Martin Markowitz, Bach‐Yen Nguyen, Eduardo Gotuzzo et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes 21 Oct 2009 110
14 Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes Grace L. Chen et al. · JAMA Open access 14 Apr 2020 109
15 Gut Microbial Carbohydrate Metabolism Hinders Weight Loss in Overweight Adults Undergoing Lifestyle Intervention With a Volumetric Diet David A. Muñiz Pedrogo, Michael Dam Jensen, Carol T. Van Dyke et al. · Mayo Clinic Proceedings Open access Aug 2018 107
16 Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study Rohit Seth Loomba, Eric Lawitz, Juan P. Frías et al. · ˜The œLancet. Gastroenterology & hepatology 12 Dec 2022 104
17 Is an Intracellular Renin–Angiotensin System Involved in Control of Cell Communication in Heart? Walmor C. De Mello · Journal of Cardiovascular Pharmacology Apr 1994 98
18 Ecological regime shift drives declining growth rates of sea turtles throughout the West Atlantic Karen A. Bjorndal et al. · Global Change Biology Open access 5 Apr 2017 87
19 Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study Chukiat Sirivichayakul, Elizabeth A Barranco-Santana, Inés Esquilin-Rivera et al. · The Journal of Infectious Diseases Open access 23 Dec 2015 87
20 The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016–17 Zika virus outbreak Eva Lathrop, Lisa Romero, Stacey Hurst et al. · The Lancet Public Health Open access 19 Jan 2018 82
21 Studies on infant diarrhea. I. A comparison of the effects of milk feeding and intravenous therapy upon the composition and volume of the stool and urine. Ramon Torres‐Pinedo, Mayrelis Lavastida, C L Rivera et al. · Journal of Clinical Investigation Open access Apr 1966 75
22 Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis Mark C. Genovese, Joel M. Kremer, Cynthia E. Kartman et al. · Lara D. Veeken Open access 5 Jan 2018 68
23 Serious Infection After Splenectomy for the Staging of Hodgkin's Disease M Ravry, NORMAN MALDONADO, ENRIQUE VÉLEZ-GARCÍA et al. · Annals of Internal Medicine Jul 1972 65
24 Low Content of Cerebral Lipids in Infants suffering from Malnutrition Marvin A. Fishman, Arthur L. Prensky, Philip R. Dodge · Nature Feb 1969 64
25 Forty‐eight‐week efficacy and safety and early CNS tolerability of doravirine (MK‐1439), a novel NNRTI, with TDF/FTC in ART‐naive HIV‐positive patients Josep M. Gatell, Javier O Morales‐Ramirez, Debbie P. Hagins et al. · Journal of the International AIDS Society Open access Nov 2014 60
26 Health conditions and lifestyle risk factors of adults living in Puerto Rico: a cross-sectional study Josiemer Mattei, Martha Taméz, Carlos F. Ríos‐Bedoya et al. · BMC Public Health Open access 12 Apr 2018 58
27 Studies on infant diarrhea. II. Absorption of glucose and net fluxes of water and sodium chloride in a segment of the jejunum. Ramon Torres‐Pinedo, C L Rivera, S Fernández · Journal of Clinical Investigation Open access Dec 1966 56
28 Clinical Cancer Genetics Disparities among Latinos Marcia Roxana Cruz-Correa, Julyann Pérez‐Mayoral, Julie Dutil et al. · Journal of Genetic Counseling Open access 12 Dec 2016 52
29 Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial Htay-Htay Han, Clemente Díaz, Camilo J. Acosta et al. · The Lancet Infectious Diseases 18 May 2021 51
30 Long-Term Efficacy, Safety, and Tolerability of Rilpivirine (RPV, TMC278) in HIV Type 1-Infected Antiretroviral-Naive Patients: Week 192 Results from a Phase IIb Randomized Trial Aimee Wilkin, Anton Louis Pozniak, Javier O Morales-Ramirez et al. · AIDS Research and Human Retroviruses 9 Sep 2011 51
31 The accuracy of needle placement in lower-limb muscles: a blinded study11No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated. Andrew J. Haig, Craig Goodmurphy, Albert R. Harris et al. · Archives of Physical Medicine and Rehabilitation Jun 2003 50
32 Long-Term Follow-Up of Antibiotic-Treated Tropical Sprue Frederick R. Rickles, FREDERICK A. KLIPSTEIN, JUAN TOMASINI et al. · Annals of Internal Medicine Feb 1972 48
33 Switching to coformulated rilpivirine ( RPV ), emtricitabine ( FTC ) and tenofovir alafenamide from either RPV , FTC and tenofovir disoproxil fumarate ( TDF ) or efavirenz, FTC and TDF : 96‐week results from two randomized clinical trials D Hagins, Chloe M. Orkin, ES Daar et al. · HIV Medicine Open access 12 Aug 2018 47
34 Reversal of pentylenetetrazole-altered swimming and neural activity-regulated gene expression in zebrafish larvae by valproic acid and valerian extract Bianca A. Torres-Hernández, Luis R. Colón, Coral Rosa-Falero et al. · Psychopharmacology Open access 11 May 2016 46
35 A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED) Robert J. Lupinacci, Richard E. Rupp, Orasri Wittawatmongkol et al. · Vaccine Open access 2023 45
36 Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial Javier O Morales-Ramirez, Johannes Richard Bogner, Jean‐Michel Molina et al. · PLoS ONE Open access 23 Oct 2018 44
37 Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer Clinton Yam et al. · Clinical Cancer Research Open access 4 May 2022 43
38 Influence of environmental tobacco smoke on vitamin C status in children Alan M Preston, Cindy A Rodriguez, Cynthia Rivera et al. · American Journal of Clinical Nutrition Open access 2003 42
39 Chronic Diseases and Associated Risk Factors Among Adults in Puerto Rico After Hurricane Maria Josiemer Mattei, Martha Taméz, June O’Neill et al. · JAMA Network Open Open access 12 Jan 2022 39
40 A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults Kevin L. Russell, Richard E. Rupp, Javier O Morales-Ramirez et al. · Human Vaccines & Immunotherapeutics Open access 15 Mar 2022 38
41 Racial/Ethnic Disparities in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights from the Healthcare Cost and Utilization Project's National Inpatient Sample Dagmar F. Hernández-Suárez, Sagar Ranka, Pedro Arturo Villablanca et al. · Cardiovascular revascularization medicine Open access 8 Apr 2019 38
42 Identification of STAC3 variants in non‐Native American families with overlapping features of Carey–Fineman–Ziter syndrome and Moebius syndrome Aida Bytyci Telegrafi, Bryn D. Webb, Sarah M. Robbins et al. · American Journal of Medical Genetics Part A Open access 4 Aug 2017 38
43 2021 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19 Antony Hsu et al. · Circulation Cardiovascular Quality and Outcomes Open access Oct 2021 36
44 Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1 Joseph J. Eron et al. · Antiviral Research Open access119 authors 4 Jul 2019 36
45 A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico Kristen M. Bauer, Ines O. Esquilin, Alberto Santiago Cornier et al. · American Journal of Tropical Medicine and Hygiene Open access 15 Jul 2015 36
46 Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension Luisam Tarrats, Gabriel Hernández, José M. Busquets et al. · International Forum of Allergy & Rhinology Open access 6 Apr 2017 33
47 Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines Marcia Roxana Cruz-Correa, Julyann Pérez‐Mayoral, Julie Dutil et al. · Hereditary Cancer in Clinical Practice Open access 21 Jan 2017 33
48 Isospora geospizae, a new coccidian parasite (Apicomplexa: Eimeriidae) from the small ground finch (Geospiza fuliginosa) and the medium ground finch (Geospiza fortis) from the Galapagos Islands Thomas E. McQuistion, Marcia H. Wilson · Systematic Parasitology Sep 1989 31
49 Diet Quality, Social Determinants, and Weight Status in Puerto Rican Children Aged 12 Years Roxana Torres, Elvia Santos, Luis Orraca et al. · Journal of the Academy of Nutrition and Dietetics Open access 22 Mar 2014 29
50 The Puerto Rican Family: Cultural Factors and Family Intervention Strategies Héctor Bird, GLORISA J. CANINO · Journal of the American Academy of Psychoanalysis Apr 1982 29

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.